João Lucas Campelo, a 17-year-old student from Teresina, Brazil, was shot by his ex-girlfriend in a private school in 2024, which left him quadriplegic. Following this tragic incident, his family sought a place for him to participate in an innovative experimental treatment using polylaminin, which has shown promising results in others suffering from similar conditions. However, João's health status has regrettably ruled out his participation in this potentially life-changing research.

The experimental treatment with polylaminin has been under study for over 20 years at the Federal University of Rio de Janeiro (UFRJ) and is believed to aid in the regeneration of nerve cells. João's mother, Cleytiana Campelo, explained that several factors prevented him from being included in the treatment trial: the bullet remains lodged in his body, his status as a minor, and the severity of his neurological condition. These limitations highlight the complexities surrounding access to advanced medical treatments post-trauma.

This incident reflects broader issues within society concerning violence in schools and the need for improved safety measures. It also raises awareness about the challenges faced by families of victims of such violence, not just in terms of immediate physical recovery but also regarding their access to experimental and potentially life-saving medical research. As discussions continue around school safety and healthcare innovation, João's situation serves as a poignant reminder of the personal impacts of such societal issues.